ImmunoGen, Inc. (IMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 5.24 |
| Open | 5.31 |
| Bid | 5.30 x 1000 |
| Ask | 5.50 x 3000 |
| Day's range | 5.28 - 5.54 |
| 52-week range | 3.10 - 7.77 |
| Volume | |
| Avg. volume | 3,542,483 |
| Market cap | 1.198B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.59 |
| Earnings date | 27 Oct 2022 - 31 Oct 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.86 |
- Business Wire
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., August 01, 2022--ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Zacks
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
ImmunoGen (IMGN) reports a wider-than-expected loss for second-quarter 2022. It also misses revenue estimates.
- Motley Fool
ImmunoGen (IMGN) Q2 2022 Earnings Call Transcript
With me today are Mark Enyedy, our president and CEO; Anna Berkenblit, our chief medical officer; Kristen Harrington-Smith, our chief commercial officer; and Susan Altschuller, our CFO. During today's call, we will review recent accomplishments for the business, our Q2 financial results, and highlight upcoming anticipated events.
© 2022 Yahoo. All rights reserved.
